{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:20:44Z","timestamp":1793046044168,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1832,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/ki.2010.318","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T09:45:21Z","timestamp":1283334321000},"page":"1171-1177","source":"Crossref","is-referenced-by-count":275,"title":["Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities"],"prefix":"10.1016","volume":"78","author":[{"given":"Leal C.","family":"Herlitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivette D.","family":"D'Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2010.318_bb0010","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. US Department of Health and Human Services, Rockville, MD. 1 December 2009. Available athttp:\/\/www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf, accessed in 5 April 2010"},{"key":"10.1038\/ki.2010.318_bb0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jac\/dkn252","article-title":"Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements","volume":"62","author":"Jimenez-Nacher","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1038\/ki.2010.318_bb0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":"Adefovir Nephrotoxicity: possible role of mitochondrial DNA depletion","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1038\/ki.2010.318_bb0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":"Cidofovir-induced end-stage renal failure","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2010.318_bb0030","series-title":"Viread (Tenofovir Disoproxill Fumarate): Highlights of Prescribing Information","author":"Gilead Sciences","year":"2010"},{"key":"10.1038\/ki.2010.318_bb0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":"The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years","volume":"21","author":"Nelson","year":"2007","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.318_bb0040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.318_bb0045","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by Tenofovir: a first case report","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kid Dis"},{"key":"10.1038\/ki.2010.318_bb0050","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-200212000-00011","article-title":"Acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity","volume":"324","author":"Coca","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1038\/ki.2010.318_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","article-title":"Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure","volume":"117","author":"Rifkin","year":"2004","journal-title":"Am J Med"},{"key":"10.1038\/ki.2010.318_bb0060","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","article-title":"Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases","volume":"35","author":"Peyriere","year":"2004","journal-title":"J Aquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.318_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/499048","article-title":"Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions","volume":"42","author":"Zimmerman","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.318_bb0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2009.486","article-title":"41-year-old HIV patient with proteinuria and progressive renal dysfunction","volume":"77","author":"Agarwala","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2010.318_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/135965350601100108","article-title":"Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy","volume":"11","author":"Cote","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1038\/ki.2010.318_bb0080","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","article-title":"Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as a common pathway","volume":"12","author":"Brinkman","year":"1998","journal-title":"AIDS"},{"key":"10.1038\/ki.2010.318_bb0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QAI.0b013e3181a666eb","article-title":"Mitochondrial tubulopathy in tenofovir disoproxil fumarate-treated rats","volume":"51","author":"Lebrecht","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1038\/ki.2010.318_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/labinvest.2009.14","article-title":"Tenofovir renal toxicity targets mitochondria of renal proximal tubules","volume":"89","author":"Kohler","year":"2009","journal-title":"Lab Invest"},{"key":"10.1038\/ki.2010.318_bb0095","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.318_bb0100","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodriguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2010.318_bb0105","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2009.142","article-title":"The nephrotoxic effects of HAART","volume":"5","author":"Izzedine","year":"2009","journal-title":"Nat Rev Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815544414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T23:06:08Z","timestamp":1685747168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815544414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0085253815544414"],"URL":"https:\/\/doi.org\/10.1038\/ki.2010.318","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725190833.793512226","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}